CureVac gets approval to scale up mRNA production
CureVac receives EMA approval for its GMP III production suite, which will be able to provide clinical trial materials and commercial supply of mRNA.
CureVac receives EMA approval for its GMP III production suite, which will be able to provide clinical trial materials and commercial supply of mRNA.
NVIDIA, King's College London, and Owkin team up to connect hospitals across the UK with federated learning, aiming to boost several fields of clinical research.
Entera Bio tips investments in manufacturing to give it an edge by driving down the cost of making its products.
Horizon Therapeutics opens South San Francisco, US, manufacturing and R&D site to tap into talent pool in biotech hotspot.
Analyst increases estimate of revenue potential of Catalent’s gene therapy unit in light of ‘insatiable’ demand.